Novavax Begins Late-Stage Trial for COVID-19 Vaccine
We may soon have a third major COVID-19 vaccine on the way, as Novavax (NVAX) seeks to join Pfizer and Moderna for approval and widespread distribution. Novavax announced today that its experimental vaccine would enter phase three study in the U.S. Its vaccine is already in phase three in the U.K. The U.S. federal government